Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain

Alland, 1997, Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression, Nature, 387, 49, 10.1038/387049a0

Archer, 1992, Transcription factor loading on the MMTV promoter, Science, 255, 1573, 10.1126/science.1347958

Arany, 1995, A family of transcriptional adaptor proteins targeted by the E1a oncoprotein, Nature, 374, 81, 10.1038/374081a0

Arias, 1994, Activation of cAMP and mitogen responsive gene relies on a common nuclear factor, Nature, 370, 226, 10.1038/370226a0

Bannister, 1995, CBP-induced stimulation of c-Fos activity is abrogated by E1a, EMBO J., 14, 4758, 10.1002/j.1460-2075.1995.tb00157.x

Bannister, 1996, The CBP coactivator is a histone acetyltransferase, Nature, 384, 641, 10.1038/384641a0

Barak, 1993, mdm2 expression is induced by wild type p53 activity, EMBO J., 12, 461, 10.1002/j.1460-2075.1993.tb05678.x

Bhattacharya, 1996, Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α, Nature, 383, 344, 10.1038/383344a0

Blackwood, 1991, Max, Science, 251, 1211, 10.1126/science.2006410

Brownell, 1996, Special HATs for special occasions, Curr. Opin. Genet. Dev., 6, 176, 10.1016/S0959-437X(96)80048-7

Buckbinder, 1995, Induction of the growth inhibitor IGF-binding protein 3 by p53, Nature, 377, 646, 10.1038/377646a0

Buckley, 1996, Alteration in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells, Cell Growth Differ., 7, 1713

Candau, 1997, Histone acetyltransferase activity and interaction with ADA2 are critical for GCN5 function in vivo, EMBO J., 16, 555, 10.1093/emboj/16.3.555

Chakravarti, 1996, Roles of CBP/p300 in nuclear receptor signaling, Nature, 383, 99, 10.1038/383099a0

Chen, 1997, Reaction of silenced, virally transduced genes by inhibitors of histone deacetylase, Proc. Natl. Acad. Sci. USA, 94, 5798, 10.1073/pnas.94.11.5798

Chiang, 1993, Expression and purification of general transcriptional factors by Flag epitope-tagging and peptide elution, Peptide Res., 6, 62

Chresta, 1996, Oddball p53 in testicular tumors, Nat. Med., 2, 745, 10.1038/nm0796-745

Chrivia, 1993, Phosphorylated CREB binds specifically to the nuclear protein CBP, Nature, 365, 855, 10.1038/365855a0

Crook, 1994, Transcriptional activation by p53 correlates with suppression of growth but not transformation, Cell, 79, 817, 10.1016/0092-8674(94)90071-X

Dai, 1996, CBP as a transcriptional coactivaor of c-Myb, Genes Dev., 10, 528, 10.1101/gad.10.5.528

El-Deiry, 1992, Definition of a consensus binding site for p53, Nat. Genet., 1, 45, 10.1038/ng0492-45

El-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 10.1016/0092-8674(93)90500-P

Engel, 1995, Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phophorylation sites and α-helix motif, J. Biol. Chem., 270, 27213, 10.1074/jbc.270.45.27213

Fiscella, 1994, The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities, Oncogene, 9, 3249

Funk, 1992, A transcriptionally active DNA-binding site for human p53 protein complexes, Mol. Cell. Biol., 12, 2866, 10.1128/MCB.12.6.2866

Gerristen, 1997, CREB-binding protein CBP/p300 are transcriptional coactivators of p65, Proc. Natl. Acad. Sci. USA, 94, 2927, 10.1073/pnas.94.7.2927

Gottlieb, 1996, p53 in growth control and neoplasia, Biochim. Biophys. Acta, 1287, 77

Gregor, 1990, The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer, Genes Dev., 4, 1730, 10.1101/gad.4.10.1730

Gu, 1997, Synergistic activation of transcription by CBP and p53, Nature, 387, 819, 10.1038/42972

Gu, 1994, Binding and suppression of the Myc transcriptional activation domain by p107, Science, 264, 251, 10.1126/science.8146655

Hall, 1996, Phosphorylation of p53 at the casein kinase site selectively regulates p53-dependent transcriptional repression but not transactivation, Nucleic Acids Res., 24, 1119, 10.1093/nar/24.6.1119

Hansen, 1997, p53; from inductive signal to cellular effect, Curr. Opin. Genet. Dev., 7, 46, 10.1016/S0959-437X(97)80108-6

Hassig, 1997, Histone deacetylase activity is required for full transcriptional repression by mSin3A, Cell, 89, 341, 10.1016/S0092-8674(00)80214-7

Heinzel, 1997, A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression, Nature, 387, 43, 10.1038/387043a0

Hendzel, 1991, Histone deacetylase is a component of the internal nuclear matrix, J. Biol. Chem., 15, 21936, 10.1016/S0021-9258(18)54727-X

Hollstein, 1991, p53 mutations in human cancers, Science, 253, 49, 10.1126/science.1905840

Hupp, 1995, Small peptides activate the latent sequence-specific DNA binding function of p53, Cell, 83, 237, 10.1016/0092-8674(95)90165-5

Hupp, 1994, Allosteric activation of latent p53 tetramers, Curr. Biol., 4, 865, 10.1016/S0960-9822(00)00195-0

Hupp, 1992, Regulation of specific DNA binding function of p53, Cell, 71, 875, 10.1016/0092-8674(92)90562-Q

Jayaraman, 1995, Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C terminus, Cell, 81, 1021, 10.1016/S0092-8674(05)80007-8

Kadosh, 1997, Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters, Cell, 89, 365, 10.1016/S0092-8674(00)80217-2

Kamei, 1996, A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors, Cell, 85, 403, 10.1016/S0092-8674(00)81118-6

Kastan, 1991, Participation of p53 protein in the cellular response to DNA damage, Cancer Res., 51, 6304

Kastan, 1992, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasis, Cell, 71, 587, 10.1016/0092-8674(92)90593-2

Kijima, 1993, Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase, J. Biol. Chem., 268, 22429, 10.1016/S0021-9258(18)41547-5

Ko, 1996, p53, Genes Dev., 10, 1054, 10.1101/gad.10.9.1054

Kuo, 1996, Transcription-linked acetylation by GCN5p of histone H3 and H4 at specific lysines, Nature, 383, 269, 10.1038/383269a0

Kwok, 1994, Nuclear protein CBP is a coactivator for the transcription factor CREB, Nature, 370, 223, 10.1038/370223a0

Laherty, 1997, Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression, Cell, 89, 349, 10.1016/S0092-8674(00)80215-9

Lee, 1995, p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches, Cell, 81, 1013, 10.1016/S0092-8674(05)80006-6

Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1

Lill, 1997, Binding and modulation of p53 by p300/CBP coactivators, Nature, 387, 823, 10.1038/42981

Lu, 1995, Human TAF31 protein is transcriptional activation coactivator of p53 protein, Proc. Natl. Acad. Sci. USA, 92, 5154, 10.1073/pnas.92.11.5154

Lundblad, 1995, Adenoviral E1a-associated protein p300 as a functional homologue of the transcriptional coactivator CBP, Nature, 374, 85, 10.1038/374085a0

Lutzker, 1996, A functionally inactive p53 protein in teracarcinoma cells is activated by either DNA damage or cellular differentiation, Nat. Med., 2, 804, 10.1038/nm0796-804

Marston, 1994, Interaction of p53 with MDM2 is independent of E6 and does not mediate wild type transformation suppressor function, Oncogene, 9, 2707

Meek, 1994, Post-translational modification of p53, Semin. Cancer Biol., 5, 203

Miyashita, 1995, Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, 80, 293, 10.1016/0092-8674(95)90412-3

Mizzen, 1996, The TAFII250 subunit of TFIID has histone acetyltransferase activity, Cell, 87, 1261, 10.1016/S0092-8674(00)81821-8

Mohammadi, 1996, Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism, Cell, 86, 577, 10.1016/S0092-8674(00)80131-2

Nagy, 1997, Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase, Cell, 89, 373, 10.1016/S0092-8674(00)80218-4

Nakajima, 1997, Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal- dependent factors, Genes Dev., 11, 738, 10.1101/gad.11.6.738

Oelgeschlager, 1996, Interaction of the co-activator CBP with Myb proteins, EMBO J., 15, 2771, 10.1002/j.1460-2075.1996.tb00637.x

Ogryzko, 1996, The transcriptional coactivator, 953

Okamoto, 1994, Cyclin G is a transcriptional target of the p53 tumor suppressor protein, EMBO J., 13, 4816, 10.1002/j.1460-2075.1994.tb06807.x

Pazin, 1997, What's up and down with histone deacetylation and transcription, Cell, 89, 325, 10.1016/S0092-8674(00)80211-1

Pietenpol, 1994, Sequence-specific transcriptional activation is essential for growth suppression by p53, Proc. Natl. Acad. Sci. USA, 91, 1998, 10.1073/pnas.91.6.1998

Ptashne, 1997, Transcriptional activation by recruitment, Nature, 386, 569, 10.1038/386569a0

Selivanova, 1997, Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain, Nat. Med., 3, 632, 10.1038/nm0697-632

Shaw, 1996, Regulation of specific DNA binding by p53, Oncogene, 12, 921

Soussi, 1990, Structural aspects of the p53 protein in relation to gene evolution, Oncogene, 5, 945

Shikama, 1997, The p300/CBP family, Trends Cell Biol., 7, 230, 10.1016/S0962-8924(97)01048-9

Thut, 1995, p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60, Science, 267, 100, 10.1126/science.7809597

Turner, 1993, Decoding the nucleosome, Cell, 75, 5, 10.1016/S0092-8674(05)80078-9

Van Lint, 1996, Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation, EMBO J., 15, 1112, 10.1002/j.1460-2075.1996.tb00449.x

Vettese-Dadey, 1996, Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro, EMBO J., 15, 2508, 10.1002/j.1460-2075.1996.tb00608.x

Wolffe, 1996, Targeting chromatin disruption, Cell, 86, 817, 10.1016/S0092-8674(00)81059-4

Wu, 1993, The p53-mdm-2 autoregulatory feedback loop, Genes Dev., 7, 1126, 10.1101/gad.7.7a.1126

Yang, 1996, A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1a, Nature, 382, 319, 10.1038/382319a0

Yoshida, 1995, Trichostatin A and trapoxin, BioEssays, 5, 423, 10.1002/bies.950170510

Yuan, 1996, Human p300 protein is a coactivator for the transcription factor MyoD, J. Biol. Chem., 271, 9009, 10.1074/jbc.271.15.9009

Zhang, 1996, Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling, Proc. Natl. Acad. Sci. USA, 93, 15092, 10.1073/pnas.93.26.15092

Zhang, 1997, Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex, Cell, 89, 357, 10.1016/S0092-8674(00)80216-0